Shares Held (Direct Ownership) 10K
n/a 3M change
n/a 12M change
Total Value Held N/A

Troy A. Ignelzi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 13 2025
BUY
Open market or private purchase
$998 $9.98 p/Share
100 Added 0.99%
10,000 Common Stock
Mar 12 2025
BUY
Open market or private purchase
$99,990 $10.1 p/Share
9,900 Added 50.0%
9,900 Common Stock

Also insider at

KRTX
Karuna Therapeutics, Inc. Healthcare
CINC
CinCor Pharma, Inc. Healthcare
CTNM
Contineum Therapeutics, Inc.
TAI

Troy A. Ignelzi

Chief Financial Officer
Boston, MA

Track Institutional and Insider Activities on RAPP

Follow Rapport Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RAPP shares.

Notify only if

Insider Trading

Get notified when an Rapport Therapeutics, Inc. insider buys or sells RAPP shares.

Notify only if

News

Receive news related to Rapport Therapeutics, Inc.

Track Activities on RAPP